How do you use Ppar in a sentence? See 2 example sentences showing how this word appears in different contexts.
Ppar in a sentence
Context around Ppar
- Average sentence length in these examples: 33 words
- Position in the sentence: 0 start, 2 middle, 0 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Ppar
- In this selection, "ppar" usually appears in the middle of the sentence. The average example has 33 words, and this corpus slice is mostly made up of statements.
- Around the word, pan, binding and alpha stand out and add context to how "ppar" is used.
- Recognizable usage signals include balanced pan ppar binding profile and protein called ppar alpha which. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "ppar" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with ppar
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Inventiva believes that lanifibranor’s moderate and balanced pan-PPAR binding profile contributes to the favorable tolerability profile that has been observed in clinical trials and pre-clinical studies to date. (31 words)
The team discovered that the rhythm of fat burning is controlled by a protein called PPAR-alpha, which is the target of drugs called fibrates, which are already used to lower lipids in the blood. (35 words)
The team discovered that the rhythm of fat burning is controlled by a protein called PPAR-alpha, which is the target of drugs called fibrates, which are already used to lower lipids in the blood. (35 words)
Inventiva believes that lanifibranor’s moderate and balanced pan-PPAR binding profile contributes to the favorable tolerability profile that has been observed in clinical trials and pre-clinical studies to date. (31 words)
Example sentences (2)
Inventiva believes that lanifibranor’s moderate and balanced pan-PPAR binding profile contributes to the favorable tolerability profile that has been observed in clinical trials and pre-clinical studies to date.
The team discovered that the rhythm of fat burning is controlled by a protein called PPAR-alpha, which is the target of drugs called fibrates, which are already used to lower lipids in the blood.